FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
On 23 April 2015, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Pregabalin Sandoz GmbH, intended for the treatment of epilepsy and generalized anxiety disorder. The applicant for this medicinal product is Sandoz GmbH, a unit of Novartis (NYSE:... More

